Robert Easterling MD (He/Him)
Critical Care Medicine, Hospital Medicine/Hospitalist, Pulmonology
Physician
Join to View Full Profile
171 Ashley AveCharleston, SC 29425
Dr. Easterling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Easterling is an internal medicine specialist based in Charleston, SC, with subspecialties in critical care medicine and pulmonology. He completed his medical education at The University of Toledo College of Medicine in 2019, followed by a residency in internal medicine at Ohio State University Hospital from 2019 to 2022. Currently, he is pursuing a fellowship in Pulmonary Disease and Critical Care Medicine at the Medical University of South Carolina, which began in 2023 and will conclude in 2026. Dr. Easterling has published several research articles, including works on sarcoidosis, checkpoint inhibitor pneumonitis, and immune checkpoint inhibitors, with his studies being cited multiple times in academic journals.
Education & Training
Medical University of South CarolinaFellowship, Pulmonary Disease and Critical Care Medicine, 2023 - 2026- Medical University of South CarolinaResidency, 2026
Ohio State University HospitalResidency, Internal Medicine, 2019 - 2022
The University of Toledo College of MedicineClass of 2019
Certifications & Licensure
OH State Medical License 2019 - 2027
SC State Medical License 2023 - 2027
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients.Anet Greib, Songzhu Zhao, Michelle Ploch, Jonathan Henricks, Robert Easterling
Oncoimmunology. 2025-12-01 - 1 citationsInvestigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitis.Meghana Moodabagil, Robert Easterling, Jing Peng, Hamzah Abu-Sbeih, Alexa Meara
The Oncologist. 2024-11-04 - Overlap syndromes in sarcoidosis: Unveiling the masquerader.Robert Easterling, W Ennis James
Respiratory Medicine. 2024-10-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
